Dapsone 25mg
- Product NDC
- 85185-104
- 11-digit product format
- 851850104
- Labeler code
- 85185
- Product ID
- 85185-104_50209cd1-afc6-53f4-e063-6394a90af9cf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Dapsone 25mg
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Solis Pharmaceuticals Inc.
- Application
- ANDA203887
- Marketing category
- ANDA
- Marketing start
- 2016-05-09
- Substance
- DAPSONE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Sulfone [EPC], Sulfones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Dapsone 25mg
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DAPSONE | 25 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 8W5C518302 |
| Rxcui | 197557, 197558 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 85185-104-01 | Dapsone 25mg | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
| 85185-104-02 | Dapsone 25mg | 100 in 1 BOTTLE | TABLET | 100 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 85185-104-01 | 85185010401 | 30 TABLET in 1 BOTTLE (85185-104-01) | 30 tablet | 2016-05-09 | No | No | Current |
| 85185-104-02 | 85185010402 | 100 TABLET in 1 BOTTLE (85185-104-02) | 100 tablet | 2016-05-09 | No | No | Current |